Reconstitution chart: 5 mg vial
| BAC water added | Concentration | Draw for 250 mcg dose | Draw for 500 mcg dose |
|---|---|---|---|
| 1 mL | 5,000 mcg/mL | 5 units | 10 units |
| 1.5 mL | 3,333 mcg/mL | 7.5 units | 15 units |
| 2 mL | 2,500 mcg/mL | 10 units | 20 units |
| 2.5 mL | 2,000 mcg/mL | 12.5 units | 25 units |
Draws are U-100 insulin syringe units (100 units = 1 mL). Formula: dose in mcg ÷ (vial mcg ÷ water mL) × 100. The calculator above handles any other combination.
About KPV
KPV is a tripeptide, just three amino acids (lysine, proline, valine), making it one of the simplest compounds in circulation. It is the C-terminal fragment of alpha-melanocyte-stimulating hormone, the piece research credits with anti-inflammatory signaling without the pigment effects of the parent hormone. It has no regulatory approval; the research base covers gut inflammation and skin models, almost entirely in animals and cell lines.
Because the molecule is small and stable, KPV gets discussed in more formats than most peptides: oral capsules and topical creams circulate alongside injectable vials. This calculator concerns only the injectable powder form. Communities typically discuss 250 to 500 mcg per injection. As everywhere on this site, that describes conversation, never a recommendation.
KPV appears in the four-part blend nicknamed KLOW (GHK-Cu, KPV, BPC-157, and TB-500), and blend vials follow the same arithmetic: total labeled peptide content, total combined dose, same equation. For a standalone 5 mg KPV vial dosed at 250 mcg, 2 mL of BAC water puts the draw at a clean 10 units and the vial holds twenty doses, which at one injection per day means a single small vial covers nearly three weeks.
Quick facts
- Status: no regulatory approval; research is mostly animal and cell-line work
- A tripeptide fragment of alpha-MSH studied for anti-inflammatory signaling
- Communities discuss 250 to 500 mcg injections; oral and topical forms also circulate
- Common vial sizes: 5 and 10 mg; appears in the KLOW blend